These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 19257830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.
    Ng AH, Frick KK, Krieger NS, Asplin JR, Cohen-McFarlane M, Culbertson CD, Kyker-Snowman K, Grynpas MD, Bushinsky DA.
    Calcif Tissue Int; 2014 May; 94(5):531-43. PubMed ID: 24481706
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK, Asplin JR, Krieger NS, Culbertson CD, Asplin DM, Bushinsky DA.
    Am J Physiol Renal Physiol; 2013 Oct 15; 305(8):F1132-8. PubMed ID: 23926184
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.
    Frick KK, Krieger NS, Bushinsky DA.
    Curr Opin Nephrol Hypertens; 2015 Jul 15; 24(4):336-44. PubMed ID: 26050120
    [Abstract] [Full Text] [Related]

  • 10. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Parker WR, Asplin JR.
    Kidney Int; 2000 Feb 15; 57(2):550-60. PubMed ID: 10652032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
    Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ.
    J Bone Miner Res; 2010 Apr 15; 25(4):830-40. PubMed ID: 19929616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats.
    Krieger NS, Stathopoulos VM, Bushinsky DA.
    Am J Physiol; 1996 Jul 15; 271(1 Pt 1):C130-5. PubMed ID: 8760038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone-Forming Rats.
    Krieger NS, Chen L, Becker J, DeBoyace S, Wang H, Favus MJ, Bushinsky DA.
    JBMR Plus; 2020 Apr 15; 4(4):e10350. PubMed ID: 32258968
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.